ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Methyltransferase-like 3 upregulation is involved in the chemoresistance of non-small cell lung cancer

Shi, Lin; Gong, Yuxin; Zhuo, Lin; Wang, Siyun; Chen, Shaobing; Ke, Bin*南方医科大学; 中山大学
Annals of Translational Medicine2022-2DOI: 10.21037/atm-21-6608
6被引7阅读
引用收藏
分享

摘要

Background: Treatments for non-small cell lung cancer (NSCLC) have improved tremendously, but therapeutic resistance is a common and major clinical challenge in treatment. Methyltransferase-like 3 (METTL3) is a ribonucleic acid (RNA) methyltransferase that has crucial functions in the development and progression of cancers, including drug resistance, by regulating N6-methyladenosine (m(6)A) modification. However, the role of METTL3 in the progression and drug resistance of NSCLC is poorly understood. @@@ Methods: The expression levels of METTL3 and AKT serine/threonine kinase 1 (AKT1) in NSCLC tissues were detected using quantitative real-time PCR (RT-qPCR), Western blots, and immunohistochemical assays. The m(6)A levels of AKT1 messenger RNA (mRNA) in NSCLC tissues were detected using m(6)A methylated RNA immunoprecipitation-quantitative polymerase chain reaction. @@@ Results: The expression levels of METTL3 and the AKT1 protein were significantly increased in NSCLC tissues, and m(6)A expression levels of AKT1 mRNA were dramatically upregulated in NSCLC tissues. Additionally, METTL3, AKT1 protein, and m(6)A levels of AKT1 mRNA were overexpressed in chemoresistant NSCLC samples, and high expression levels of METTL3 and AKT1 were correlated with poor patient survival, especially in chemoresistant NSCLC patients. Further, AKT1 protein expression and m(6)A levels of AKT1 mRNA were positively correlated with METTL3 expression, and AKT1 protein expression was positively correlated with m(6)A levels of AKT1 mRNA. Moreover, METTL3 and AKT1 protein expression levels were significantly associated with cisplatin susceptibility, tumor, node, metastasis stage, and lymph node metastasis. @@@ Conclusions: Taken together, our results indicate that METTL3 contributes to the progression and chemoresistance of NSCLC by promoting AKT1 protein expression through regulating AKT1 mRNA m(6)A levels, and may provide an efficient therapeutic intervention target for overcoming chemoresistance in NSCLC.

学科与关键词

关键词
Non-small cell lung cancer (NSCLC)methyltransferase-like 3 (METTL3)AKT serine/threonine kinase 1 (AKT1)chemoresistancebiomarker
相关
加载中…
  • METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy
    Sun, Yueqin; Shen, Weitao; Hu, Shulu; Lyu, Qiong; Wang, Qiongyao; Wei, Ting*; Zhu, Weiliang*; Zhang, Jian*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42(1): 65.被引 16
  • Effect of m6A methyltransferase METTL3-mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer
    Li, Sumei; Jiang, Fengru; Chen, Feiyu; Deng, Yingzhao; Pan, Xiaoping*JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2022, 36(1): e22922.被引 17
  • m6A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer
    Xue, Lei; Li, Jun; Lin, Yihui; Liu, Degang; Yang, Qiang; Jian, Jinting; Peng, Jiangzhou*Journal of Cellular Physiology, 2021, 236(4): 2649-2658.被引 112
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2022-02
卷期
第 10 卷, 第 3 期
页码
139
DOI
10.21037/atm-21-6608
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82074159, 81874381]; Natural Science Foundation of Guangdong Province of China [2021A1515011611, 2021A1515010491]

作者

  • S

    Shi, Lin (第一作者)

    southern med univ

  • G

    Gong, Yuxin

    southern med univ

查看全部 6 位作者收起作者
  • Z

    Zhuo, Lin

    southern med univ

  • W

    Wang, Siyun

    southern med univ

  • C

    Chen, Shaobing

    southern med univ

  • K

    Ke, Bin (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417